Dr. Zhuohan Hu (President and CEO) of Research Institute for Liver Diseases (Shanghai) Co., Ltd. (RILD) visited the National Center for Drug Screening (NCDS) in the afternoon of February 26, 2016. Professor Ming-Wei Wang, Director of NCDS, warmly greeted him and discussed with him about organizing an Asia-Pacific region drug metabolism forum in 2018, among other topics.